Urology Medical News about Testicular neoplasm

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy
World Journal of Urology, 07/30/09

Westermann DH et al. – Testis cancer is the most frequent solid malignancy in young men. The majority of patients present with clinical stage I disease and about 50% of them are nonseminomatous germ cell tumors. This review provides information on the potential of chemotherapy to achieve a higher chance of cure for patients with high–risk clinical stage I disease than its therapeutic alternatives and addresses toxicity and dose dependency.

<< Previous
Treatment of clitoromegaly of culturally diverse patients

Next >>
Effect of Clinical Variables and Immunosuppression on Serum...

Clinicopathological Study of Regressed Testicular Tumors (Apparent Extragonadal Germ Cell Neoplasms)
The Journal of Urology, 10/22/09 Relevance Score: 67%

Testicular cancer: addressing the psychosexual issues
British Journal of Nursing, 10/27/09 Relevance Score: 66%

Epithelioid angiosarcoma: A neoplasm with potential diagnostic challenges
Diagnostic Cytopathology, 10/14/09 Relevance Score: 64%

Scrotal sonography revisited
Journal of Clinical Ultrasound, 10/05/09 Relevance Score: 64%

Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy
Annals of Oncology, 11/04/09 Relevance Score: 63%